CYP2D6 genotype dependent oxycodone metabolism in postoperative patients. - Wikidata - awgldk - TriplyDB

CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.

CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.

http://www.wikidata.org/entity/Q34653610

about

A new therapeutic option for postoperative pain management with oxycodone HCI injection Neuropathic Pain due to Small Fiber Neuropathy in Aging: Current Management and Future Prospects Genetic determinants of fetal opiate exposure and risk of neonatal abstinence syndrome: Knowledge deficits and prospects for future research.Effects of aprepitant on the pharmacokinetics of controlled-release oral oxycodone in cancer patients.Perspectives on Intravenous Oxycodone for Control of Postoperative Pain.Laparoscopic surgery: a narrative review of pharmacotherapy in pain management.Personalizing supportive care in oncology patients using pharmacogenetic-driven treatment pathways.SCAMPs for Multimodal Post-Operative Analgesia: A Concept to Standardize and Individualize Care.Codeine and opioid metabolism: implications and alternatives for pediatric pain management.Review of Opioid Pharmacogenetics and Considerations for Pain Management.Prediction of Metabolic Interactions With Oxycodone via CYP2D6 and CYP3A Inhibition Using a Physiologically Based Pharmacokinetic Model.The pharmacogenetics of medications used in general anesthesia.Population pharmacokinetics and analgesic potency of oxycodone.Value of Supportive Care Pharmacogenomics in Oncology Practice.

P2860

Q26747676-CE9D2D7C-9248-4BF8-803F-FF8ADAE049F1 Q26799409-709860F6-8344-4D01-B25A-9B3857259864 Q33833207-C082BBD7-21B0-47DA-BF00-ED5D79A0FD76 Q34046633-E61EF0F7-74D1-4178-B141-69EB908D7F12 Q38590899-49662340-F214-4DAC-86F7-D448FA911960 Q38614128-9D318DF4-D6CC-4D3E-859C-82F11F36696A Q38731079-8FC32169-8746-47F8-BD5F-3BC958030CCB Q38985139-FA154BDF-CF9A-4A83-AF87-19C8C2D553D9 Q39190293-5C04B22B-1F9D-4979-93C5-B33CCA97E6E3 Q39430407-A91C12B1-540D-40F2-81A1-82F3F54CF391 Q41678423-C858BDCF-A434-43BB-87D3-F3D33086AEA9 Q47213395-A67007F2-9BB4-4B78-9AA6-D383DF8D3CEE Q47395038-8C675F13-2B80-4D99-8CE6-C273834216A4 Q52603826-30EC91A9-E1EE-4D58-BB02-12785AD63F89

P2860

CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.

http://www.wikidata.org/entity/Q34653610

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.

@ast

CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.

@en

CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.

@nl

type

label

CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.

@ast

CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.

@en

CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.

@nl

prefLabel

CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.

@ast

CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.

@en

CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.

@nl

P1433

Q34653610-B93B211F-E1EB-4C84-A873-EF6CBB638E9E

P1476

Q34653610-5661F55A-F71A-4A3A-ADD7-5A2DCAC67A43

P2093

Q34653610-5BFFF3C7-2CCD-4829-BC6F-1A22B4091279

Q34653610-6E7AADF0-124A-44A5-AE7B-B9E4FA706D42

Q34653610-937F94B2-9DBF-4540-95F1-CB3F77F5634E

Q34653610-AF82130F-F244-45AF-A048-5CBF2CA820A9

Q34653610-EA2D2928-3A29-4E62-9FB7-7D2C76D5240C

P2860

Q34653610-0185221F-D894-4A91-9344-5D49B5148DC8

Q34653610-0E4C9479-84CF-4B80-87CB-FAB7F8FBF740

Q34653610-1157B5C7-4668-41E4-8E12-8FE226434267

Q34653610-2200C673-254F-43E2-BBAD-35D23EA0CBAB

Q34653610-24EA366A-6BB9-403D-9850-3CCD1EC56BCB

Q34653610-32B042BD-8C8D-44B6-A0CD-F4BB57BF47FB

Q34653610-3668CB9F-E03F-49F1-A20F-34B95E76FAA1

Q34653610-38917B79-8F19-4692-90C4-8C2BA82D82EA

Q34653610-3A9BF16A-005B-4CD9-A555-01450288AC83

Q34653610-3ACFDAE8-2940-485A-ABF4-04B70061391E

P304

Q34653610-B58A342F-1F36-411F-AD65-282F68B5B1F9

P31

Q34653610-C8599C50-0385-448A-A299-7C84FE270C8A

P356

Q34653610-9C6B671D-E5C5-4F9C-8C38-2D79BD475447

P407

Q34653610-3E2974C4-3890-4FB3-93ED-7695DB5FF32C

P433

Q34653610-61C9FAA9-30FE-4E15-9500-F75541A84250

P478

Q34653610-DE4364B5-F8A4-468D-873C-3E8536454C6D

P50

Q34653610-37D9C22B-B1D3-4F9E-A41B-B408EDDD0681

P577

Q34653610-24AD2305-16E5-4155-97EA-520672946B77

P5875

Q34653610-DAE08CE7-6393-4F47-BEE3-99BA1D34FFB3

P698

Q34653610-90D100AD-C01C-41FA-9875-282C4D99FAB9

P932

Q34653610-9A588AA6-849B-461C-8152-9435B60BDAFB

P356

JOURNAL.PONE.0060239

P1433

P1476

CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.

@en

P2093

Frank Stuber

http://www.w3.org/2001/XMLSchema#string

Lan Zhang

http://www.w3.org/2001/XMLSchema#string

Lutz E Lehmann

http://www.w3.org/2001/XMLSchema#string

Malte Book

http://www.w3.org/2001/XMLSchema#string

Ulrike M Stamer

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety

Activation of G-proteins by morphine and codeine congeners: insights to the relevance of O- and N-demethylated metabolites at mu- and delta-opioid receptors.

Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites.

Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.

Rifampin greatly reduces the plasma concentrations of intravenous and oral oxycodone.

Clinical implications of CYP3A polymorphisms.

Concurrent assessment of hepatic and intestinal cytochrome P450 3A activities using deuterated alfentanil

Complicated pain management in a CYP450 2D6 poor metabolizer.

Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.

Determination of oxycodone in plasma and identification of a major metabolite.

P304

e60239

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0060239

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236106791

http://www.w3.org/2001/XMLSchema#string

P698

23555934

http://www.w3.org/2001/XMLSchema#string

P932

3610662

http://www.w3.org/2001/XMLSchema#string